CCI
17
-11
VIX
58
3
DFS
68
-2
APH
81
-2
FAST
55
-2
PX
66
-2
XRX
28
-2
D
32
4
SLB
38
-3
NWSA
73
-3
SJM
11
-17
WU
26
-2
FCX
40
-2
PPL
82
2
FIS
78
-4
OMC
50
2
AAL
20
2
KMX
47
3
TAP
53
-3
WEC
75
2
CCI
17
-11
VIX
58
3
DFS
68
-2
APH
81
-2
FAST
55
-2
PX
66
-2
XRX
28
-2
D
32
4
SLB
38
-3
NWSA
73
-3
SJM
11
-17
WU
26
-2
FCX
40
-2
PPL
82
2
FIS
78
-4
OMC
50
2
AAL
20
2
KMX
47
3
TAP
53
-3
WEC
75
2
Financhill
Back

Genmab AS Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
60

GMAB
Genmab AS

Last Price:
$20.95
Seasonality Move:
12.67%

7 Day Trial

ALL ACCESS PASS

$ 7

Genmab AS Stock Forecast

  • Over the next 52 weeks, Genmab AS has on average historically risen by 25.5% based on the past 12 years of stock performance.
  • Genmab AS has risen higher in 8 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
  • Is Genmab AS Stock Undervalued?
    The current Genmab AS [GMAB] share price is $20.63. The Score for GMAB is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • GMAB is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Genmab AS Stock Go Up Next Year?

  • Over the next 52 weeks, Genmab AS has on average historically risen by 25.5% based on the past 12 years of stock performance.

Genmab AS Stock Rating

Buy
60
Genmab AS (GMAB) is a Buy

Is Genmab AS overpriced?

  • Genmab AS has risen higher in 8 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

Genmab AS Stock Price History

Is GMAB stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GMAB is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Denmark
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
genmab.com

52-Week Data

52-Week High:
30.41
52-Week Low:
17.24

Prediction Charts

Market Cap:
13.1B
Price in USD:
20.63
Volume:
783.4K
Beta:
0.71

Technical Analysis

SMA50:
20.59
SMA100:
20.66
SMA200:
22.85
52-Wk Change:
-26.71%

Stock Predictions

  • Is Genmab AS stock public?
    Yes, Genmab AS is a publicly traded company.
  • What is the Genmab AS stock quote today?
    The Genmab AS stock price is 20.63 USD today.
  • How to buy Genmab AS stock online?
    You can buy Genmab AS shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-8 18.89 17.98 18.92 17.77
Apr-9 17.69 18.83 18.97 17.24
Apr-10 18.68 18.01 18.70 17.58
Apr-11 18.64 18.81 18.88 18.44
Apr-14 19.20 19.32 19.37 19.07
Apr-15 19.65 19.51 19.69 19.35
Apr-16 19.55 19.55 19.74 19.42
Apr-17 19.47 20.04 20.16 19.42
Apr-21 20.00 20.07 20.18 19.73
Apr-22 19.68 20.27 20.29 19.68
Apr-23 20.29 20.13 20.39 20.02
Apr-24 20.35 20.54 20.55 20.25
Apr-25 20.47 20.59 20.64 20.36
Apr-28 20.65 20.63 20.73 20.46

Genmab AS Earnings

Genmab AS Earnings Report: Per Share Genmab AS Earnings Q1 Q2 Q3 and Q4 last year and next year.

Genmab AS Forecast Revenue Growth

Genmab AS Stock Analysis: Historical quarterly revenues per share for Genmab AS and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.17 per share, an increase next quarter of $5.15 per share, an increase this year of $0.17 per share, and an increase next year of $0.31 per share.

* Genmab AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.